Evidence map›Paper›PMID 26714855›Full record

ArticleBMC nephrology2015

Partial nephrogenic diabetes insipidus caused by a novel AQP2 variation impairing trafficking of the aquaporin-2 water channel.

Pia Dollerup, Troels Møller Thomsen, Lene N Nejsum, Mia Færch, Martin Österbrand, Niels Gregersen, Søren Rittig, Jane H Christensen, Thomas J Corydon

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Aquaporins in Urinary System.Advances in experimental medicine and biology · 2023
    Article
  3. Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus withClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2022
    Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Pia DollerupDepartment of Biomedicine, Aarhus University, Wilhelm Meyers Allé 4, 8000, Aarhus, Denmark. pd@biomed.au.dk.
Troels Møller ThomsenDepartment of Biomedicine, Aarhus University, Wilhelm Meyers Allé 4, 8000, Aarhus, Denmark. troels.m.thomsen@gmail.com.
Lene N NejsumDepartment of Molecular Biology and Genetics and iNANO, Aarhus University, Aarhus, Denmark. nejsum@mbg.au.dk.
Mia FærchDepartment of Pediatrics, Aarhus University Hospital, Aarhus, Denmark. MIA.FAERCH@KI.AU.DK.
Martin ÖsterbrandDepartment of Pediatrics, Queen Silvia Children's Hospital, Gothenburg, Sweden. martin.osterbrand@vgregion.se.
Niels GregersenResearch Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. NIG@KI.AU.DK.
Søren RittigDepartment of Pediatrics, Aarhus University Hospital, Aarhus, Denmark. RITTIG@KI.AU.DK.
Jane H ChristensenDepartment of Biomedicine, Aarhus University, Wilhelm Meyers Allé 4, 8000, Aarhus, Denmark. jhc@biomed.au.dk.
Thomas J CorydonDepartment of Biomedicine, Aarhus University, Wilhelm Meyers Allé 4, 8000, Aarhus, Denmark. corydon@biomed.au.dk.
Aarhus University · DKAarhus University Hospital · DKDrottning Silvias barn- och ungdomssjukhus · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutosomal dominant inheritance of congenital nephrogenic diabetes insipidus (CNDI) is rare and usually caused by variations in the AQP2 gene. We have investigated the genetic and molecular background underlying symptoms of diabetes insipidus (DI) in a Swedish family with autosomal dominant inheritance of the condition.

methodsThe proband and her father were subjected to water deprivation testing and direct DNA sequencing of the coding regions of the AQP2 and AVP genes. Madin-Darby canine kidney (MDCK) cells stably expressing AQP2 variant proteins were generated by lentiviral gene delivery. Localization of AQP2 variant proteins in the cells under stimulated and unstimulated conditions was analyzed by means of immunostaining and confocal laser scanning microscopy. Intracellular trafficking of AQP2 variant proteins was studied using transient expression of mutant dynamin2-K44A-GFP protein and AQP2 variant protein phosphorylation levels were assessed by Western blotting analysis.

resultsClinical and genetic data suggest that the proband and her father suffer from partial nephrogenic DI due to a variation (g.4807C > T) in the AQP2 gene. The variation results in substitution of arginine-254 to tryptophan (p.R254W) in AQP2. Analysis of MDCK cells stably expressing AQP2 variant proteins revealed disabled phosphorylation, impaired trafficking and intracellular accumulation of AQP2-R254W protein. Notably, blocking of the endocytic pathway demonstrated impairment of AQP2-R254W to reach the cell surface.

conclusionsPartial CNDI in the Swedish family is caused by an AQP2 variation that seems to disable the encoded AQP2-R254W protein to reach the subapical vesicle population as well as impairing its phosphorylation at S256. The AQP2-R254W protein is thus unable to reach the plasma membrane to facilitate AVP mediated urine concentration.

Indexed as

Aquaporin 2Diabetes Insipidus, NephrogenicFemaleHumansInfantMaleMutationPedigreeProtein TransportAquaporin 2

Identifiers

PMID26714855
PMCPMC4696136
OpenAlexW2201620137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.